Inxight Drugs

U.S. Department of Health & Human Services Divider Arrow

National Institutes of Health Divider Arrow

NCATS

This repository is under review for potential modification in compliance with Administration directives.

Return Home Inxight Drugs

Home
Browse Drugs
Search
- Structure Search
- Sequence Search
Downloads
About

Show Filters

Hide Filters

Development Status

Other

1,562

US Approved Rx

1,340

US Approved Allergenic Extract

602

US Previously Marketed

198

Possibly Marketed Outside US

84

All Match

Any Match

Exclude Selected

Exclude Selected

Primary Target

DNA

50

Bacterial penicillin-binding protein

38

Glucocorticoid receptor

32

Mu opioid receptor

30

Dopamine D2 receptor

27

All Match

Any Match

Exclude Selected

Exclude Selected

Highest Phase

Approved

1,314

Phase III

2

Not Provided

1

Phase I

1

Phase II

1

All Match

Any Match

Exclude Selected

Exclude Selected

Approval Year

Unknown

1,596

1972

137

1941

106

1965

105

1967

95

All Match

Any Match

Exclude Selected

Exclude Selected

Condition

Hypertension

77

Unknown

59

Pain

48

Breast cancer

33

Rheumatoid arthritis

30

All Match

Any Match

Exclude Selected

Exclude Selected

Treatment Modality

Primary

842

Curative

219

Palliative

188

Preventing

111

Diagnostic

105

All Match

Any Match

Exclude Selected

Exclude Selected

CNS Activity

CNS Penetrant

368

CNS Active

308

CNS Non-penetrant

197

All Match

Any Match

Exclude Selected

Exclude Selected

Originator

Merck

35

Pfizer

30

Eli Lilly

24

Bristol-Myers Squibb

21

AstraZeneca

16

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Class

Chemical

1,277

Concept

1,237

Structurally Diverse

1,014

Protein

198

Mixture

75

All Match

Any Match

Exclude Selected

Exclude Selected

INN Stem

Chemical substance(-ine)

1

All Match

Any Match

Exclude Selected

Exclude Selected

Code System

NDF-RT

3,847

FDA UNII

2,613

RXCUI

2,190

DRUG BANK

2,180

DAILYMED

2,165

All Match

Any Match

Exclude Selected

Exclude Selected

Protein Type

MONOCLONAL ANTIBODY

58

ENZYME

10

HORMONE

9

CYTOKINE

5

GROWTH FACTOR

3

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 1

ANTINEOPLASTIC AND IMMUNOMODULATING AGENTS

237

ANTIINFECTIVES FOR SYSTEMIC USE

205

NERVOUS SYSTEM

199

ALIMENTARY TRACT AND METABOLISM

190

CARDIOVASCULAR SYSTEM

158

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 2

ANTINEOPLASTIC AGENTS

151

OPHTHALMOLOGICALS

118

ANTIBACTERIALS FOR SYSTEMIC USE

101

ANTIVIRALS FOR SYSTEMIC USE

61

IMMUNOSUPPRESSANTS

49

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 3

OTHER ANTINEOPLASTIC AGENTS

103

DIRECT ACTING ANTIVIRALS

61

IMMUNOSUPPRESSANTS

49

OTHER BETA-LACTAM ANTIBACTERIALS

37

ANTIINFECTIVES

36

All Match

Any Match

Exclude Selected

Exclude Selected

ATC Level 4

Protein kinase inhibitors

37

Other antineoplastic agents

34

Antibiotics

32

Monoclonal antibodies

24

Selective immunosuppressants

23

All Match

Any Match

Exclude Selected

Exclude Selected

Substance Form

Principal Form

2,382

Salts, Hydrates, Esters, etc.

231

All Match

Any Match

Exclude Selected

Exclude Selected

Search results for "Established Pharmacologic Class [EPC]" in comments (approximate match)

Showing 3841 - 3847 of 3,847 results

First page
Previous page
385
Next page disabled
Next page disabled

INDIUM IN-111 PENTETREOTIDE KIT

M312JJ6Z32

Status:

Other

Class:

CONCEPT

MANNITOL 300

3OWL53L36A

Status:

Other

Class:

CONCEPT

MANNITOL 2080

3OWL53L36A

Status:

Other

Class:

CONCEPT

MANNITOL 60

3OWL53L36A

Status:

Other

Class:

CONCEPT

TECHNETIUM TC-99M PENTETATE KIT

VW78417PU1

Status:

Other

Class:

CONCEPT

GRISEOFULVIN, ULTRAMICROCRYSTALLINE

32HRV3E3D5

Status:

Other

Class:

CONCEPT

GRISEOFULVIN, MICROCRYSTALLINE

32HRV3E3D5

Status:

Other

Class:

CONCEPT

Showing 3841 - 3847 of 3,847 results

First page
Previous page
385
Next page disabled
Next page disabled

HHS VULNERABILITY DISCLOSURE

For language access assistance, contact the NCATS Public Information Officer

National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966


			version 1.1